{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:19:46Z","timestamp":1790752786815,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The National Science and Technology Major Project for Major New Drugs Innovation and Development","award":["2018ZX0973400"],"award-info":[{"award-number":["2018ZX0973400"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171780"],"award-info":[{"award-number":["82171780"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10067-022-06259-z","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T01:02:13Z","timestamp":1660093333000},"page":"3697-3706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development and validation of equations for conversion from DAS28ESR and DAS28CRP to the SDAI in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"41","author":[{"given":"Li-ming","family":"Pu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-jia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-nan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-da","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-zi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"issue":"23","key":"6259_CR1","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365(23):2205\u20132219. https:\/\/doi.org\/10.1056\/NEJMra1004965","journal-title":"N Engl J Med"},{"issue":"4","key":"6259_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4):631\u2013637. https:\/\/doi.org\/10.1136\/ard.2009.123919","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"6259_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41584-019-0279-6","volume":"15","author":"D Aletaha","year":"2019","unstructured":"Aletaha D, Smolen JS (2019) Remission in rheumatoid arthritis: missing objectives by using inadequate DAS28 targets. Nat Rev Rheumatol 15(11):633\u2013634. https:\/\/doi.org\/10.1038\/s41584-019-0279-6","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"6259_CR4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/rheumatology\/kem007","volume":"46","author":"M Mierau","year":"2007","unstructured":"Mierau M, Schoels M, Gonda G, Fuchs J, Aletaha D, Smolen JS (2007) Assessing remission in clinical practice. Rheumatology (Oxford) 46(6):975\u2013979. https:\/\/doi.org\/10.1093\/rheumatology\/kem007","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"6259_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","volume":"79","author":"JS Smolen","year":"2020","unstructured":"Smolen JS, Landew\u00e9 RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A et al (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis 79(6):685\u2013699. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216655","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6259_CR6","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1136\/annrheumdis-2016-210602","volume":"76","author":"B Combe","year":"2017","unstructured":"Combe B, Landewe R, Daien CI, Hua C, Aletaha D, \u00c1lvaro-Gracia JM et al (2017) 2016 update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis 76(6):948\u2013959. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210602","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"6259_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Landew\u00e9 R, Breedveld FC, Buch M, Burmester G, Dougados M et al (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 73(3):492\u2013509. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204573","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6259_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/acr.22783","volume":"68","author":"JA Singh","year":"2016","unstructured":"Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC et al (2016) 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res 68(1):1\u201325. https:\/\/doi.org\/10.1002\/acr.22783","journal-title":"Arthritis Care Res"},{"issue":"5","key":"6259_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/acr.21641","volume":"64","author":"JA Singh","year":"2012","unstructured":"Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM et al (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 64(5):625\u2013639. https:\/\/doi.org\/10.1002\/acr.21641","journal-title":"Arthritis Care Res"},{"issue":"11","key":"6259_CR10","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1002\/acr.23825","volume":"71","author":"A Dasgupta","year":"2019","unstructured":"Dasgupta A, Ward MM (2019) Translating treatment effects between rheumatoid arthritis activity measures and American College of Rheumatology responses in direct comparison trials. Arthritis Care Res 71(11):1482\u20131487. https:\/\/doi.org\/10.1002\/acr.23825","journal-title":"Arthritis Care Res"},{"key":"6259_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i1777","volume":"353","author":"GS Hazlewood","year":"2016","unstructured":"Hazlewood GS, Barnabe C, Tomlinson G, Marshall D, Devoe D, Bombardier C (2016) Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis. BMJ (Clinical research ed) 353:i1777. https:\/\/doi.org\/10.1136\/bmj.i1777","journal-title":"BMJ (Clinical research ed)"},{"issue":"5","key":"6259_CR12","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acr.21649","volume":"64","author":"J Anderson","year":"2012","unstructured":"Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K et al (2012) Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res 64(5):640\u2013647. https:\/\/doi.org\/10.1002\/acr.21649","journal-title":"Arthritis Care Res"},{"issue":"1","key":"6259_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van\u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis and rheumatism 38(1):44\u20138. https:\/\/doi.org\/10.1002\/art.1780380107","journal-title":"Arthritis and rheumatism."},{"key":"6259_CR14","unstructured":"Fransen J, Welsing PM, Keijzer RM , Van Riel PLCM (2004) Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis 62(Suppl 1):151"},{"issue":"2","key":"6259_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/rheumatology\/keg072","volume":"42","author":"JS Smolen","year":"2003","unstructured":"Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G et al (2003) A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 42(2):244\u2013257. https:\/\/doi.org\/10.1093\/rheumatology\/keg072","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"6259_CR16","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1002\/art.21235","volume":"52","author":"D Aletaha","year":"2005","unstructured":"Aletaha D, Ward MM, Machold KP, Nell VP, Stamm T, Smolen JS (2005) Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 52(9):2625\u20132636. https:\/\/doi.org\/10.1002\/art.21235","journal-title":"Arthritis Rheum"},{"issue":"2","key":"6259_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s10165-012-0652-7","volume":"23","author":"M Fujiwara","year":"2013","unstructured":"Fujiwara M, Kita Y (2013) Reexamination of the assessment criteria for rheumatoid arthritis disease activity based on comparison of the Disease Activity Score 28 with other simpler assessment methods. Mod Rheumatol 23(2):260\u2013268. https:\/\/doi.org\/10.1007\/s10165-012-0652-7","journal-title":"Mod Rheumatol"},{"issue":"2","key":"6259_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s10165-010-0367-6","volume":"21","author":"T Matsui","year":"2011","unstructured":"Matsui T, Kuga Y, Nishino J, Kaneko A, Eto Y, Tohma S (2011) Comparison of composite disease activity indices for rheumatoid arthritis. Mod Rheumatol 21(2):134\u2013143. https:\/\/doi.org\/10.1007\/s10165-010-0367-6","journal-title":"Mod Rheumatol"},{"issue":"6","key":"6259_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.rbre.2014.12.005","volume":"55","author":"MMdC Medeiros","year":"2015","unstructured":"Medeiros MMdC, Oliveira BMGBd, Cerqueira JVMd, Quixad\u00e1 RTdS, Oliveira \u00cdMAXd (2015) Correlation of rheumatoid arthritis activity indexes (Disease Activity Score 28 measured with ESR and CRP, simplified disease activity index and clinical disease activity index) and agreement of disease activity states with various cut-off points in a Northeastern Brazilian population. Revista Brasileira de Reumatologia (English Edition) 55(6):477\u201384. https:\/\/doi.org\/10.1016\/j.rbre.2014.12.005","journal-title":"Revista Brasileira de Reumatologia (English Edition)"},{"key":"6259_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12891-015-0718-8","volume":"16","author":"IB Slama","year":"2015","unstructured":"Slama IB, Allali F, Lakhdar T, El Kabbaj S, Medrare L, Ngeuleu A et al (2015) Reliability and validity of CDAI and SDAI indices in comparison to DAS-28 index in Moroccan patients with rheumatoid arthritis. BMC Musculoskelet Disord 16:268. https:\/\/doi.org\/10.1186\/s12891-015-0718-8","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"6259_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/rheumatology\/keu313","volume":"54","author":"FM Martins","year":"2015","unstructured":"Martins FM, da Silva JA, Santos MJ, Vieira-Sousa E, Duarte C, Santos H et al (2015) DAS28, CDAI and SDAI cut-offs do not translate the same information: results from the Rheumatic Diseases Portuguese Register Reuma.pt. Rheumatology (Oxford, England). 54(2):286\u201391. https:\/\/doi.org\/10.1093\/rheumatology\/keu313","journal-title":"Rheumatology (Oxford, England)."},{"issue":"12","key":"6259_CR22","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1097\/cm9.0000000000001517","volume":"134","author":"X Song","year":"2021","unstructured":"Song X, Wang YH, Li MT, Duan XW, Li HB, Zeng XF (2021) Chinese registry of rheumatoid arthritis: IV. Correlation and consistency of rheumatoid arthritis disease activity indices in China. Chin Med J 134(12):1465\u201370. https:\/\/doi.org\/10.1097\/cm9.0000000000001517","journal-title":"Chin Med J"},{"issue":"11","key":"6259_CR23","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1111\/1756-185x.13227","volume":"21","author":"R Restrepo-Correa","year":"2018","unstructured":"Restrepo-Correa R, Rodr\u00edguez-Padilla LM, Zapata-Castellanos AL, Ocampo A, Garc\u00eda JJ, Mu\u00f1oz-Grajales C et al (2018) Concordance and correlation of activity indices in patients with rheumatoid arthritis in northwestern Colombia: a cross-sectional study. Int J Rheum Dis 21(11):1946\u20131954. https:\/\/doi.org\/10.1111\/1756-185x.13227","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"6259_CR24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/art.39996","volume":"69","author":"JS Smolen","year":"2017","unstructured":"Smolen JS, Aletaha D, Gruben D, Zwillich SH, Krishnaswami S, Mebus C (2017) Brief report: remission rates with tofacitinib treatment in rheumatoid arthritis: a comparison of various remission criteria. Arthritis & rheumatology (Hoboken, NJ) 69(4):728\u2013734. https:\/\/doi.org\/10.1002\/art.39996","journal-title":"Arthritis & rheumatology (Hoboken, NJ)"},{"issue":"2","key":"6259_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jbspin.2011.04.008","volume":"79","author":"C Gaujoux-Viala","year":"2012","unstructured":"Gaujoux-Viala C, Mouterde G, Baillet A, Claudepierre P, Fautrel B, Le Lo\u00ebt X et al (2012) Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI. Joint bone spine 79(2):149\u2013155. https:\/\/doi.org\/10.1016\/j.jbspin.2011.04.008","journal-title":"Joint bone spine"},{"issue":"3","key":"6259_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5152\/eurjrheum.2020.19199","volume":"7","author":"KP Leong","year":"2020","unstructured":"Leong KP, Tan JWL, Gao X, Koh ET (2020) Conversion among the 28-joint count activity indices for rheumatoid arthritis. Eur J Rheumatol 7(3):105\u2013111. https:\/\/doi.org\/10.5152\/eurjrheum.2020.19199","journal-title":"European journal of rheumatology"},{"issue":"12","key":"6259_CR27","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1002\/art.30634","volume":"63","author":"D Aletaha","year":"2011","unstructured":"Aletaha D, Smolen JS (2011) Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints. Arthritis Rheum 63(12):3702\u20133711. https:\/\/doi.org\/10.1002\/art.30634","journal-title":"Arthritis Rheum"},{"issue":"11","key":"6259_CR28","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1136\/ard.2004.034371","volume":"64","author":"D van der Heijde","year":"2005","unstructured":"van der Heijde D, Klareskog L, Boers M, Landew\u00e9 R, Codreanu C, Bolosiu HD et al (2005) Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results. Ann Rheum Dis 64(11):1582\u20131587. https:\/\/doi.org\/10.1136\/ard.2004.034371","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6259_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13075-017-1346-5","volume":"19","author":"M Schoels","year":"2017","unstructured":"Schoels M, Alasti F, Smolen JS, Aletaha D (2017) Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition. Arthritis Res Ther 19(1):155. https:\/\/doi.org\/10.1186\/s13075-017-1346-5","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"6259_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315\u2013324. https:\/\/doi.org\/10.1002\/art.1780310302","journal-title":"Arthritis Rheum"},{"issue":"7","key":"6259_CR31","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/acr.23914","volume":"72","author":"M Inoue","year":"2020","unstructured":"Inoue M, Kanda H, Tateishi S, Fujio K (2020) Evaluation of response criteria in rheumatoid arthritis treated with biologic disease-modifying antirheumatic drugs. Arthritis Care Res 72(7):942\u2013949. https:\/\/doi.org\/10.1002\/acr.23914","journal-title":"Arthritis Care Res"},{"key":"6259_CR32","doi-asserted-by":"crossref","unstructured":"Stuart A(1955) A test for homogeneity of the marginal distributions in a two-way classification. Biometrika 42(3\u20134):412\u2013416","DOI":"10.1093\/biomet\/42.3-4.412"},{"issue":"535","key":"6259_CR33","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1192\/bjp.116.535.651","volume":"116","author":"AE Maxwell","year":"1970","unstructured":"Maxwell AE (1970) Comparing the classification of subjects by two independent judges. B J Psychiatry: J Ment Sci 116(535):651\u2013655. https:\/\/doi.org\/10.1192\/bjp.116.535.651","journal-title":"The British journal of psychiatry: the journal of mental science"},{"key":"6259_CR34","doi-asserted-by":"crossref","unstructured":"McNemar Q (1947) Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika 12(2):153\u2013157","DOI":"10.1007\/BF02295996"},{"key":"6259_CR35","doi-asserted-by":"publisher","unstructured":"Bowker AH (1948) A test for symmetry in contingency tables. J Am Stat Assoc\u00a043(244). https:\/\/doi.org\/10.2307\/2280710","DOI":"10.2307\/2280710"},{"key":"6259_CR36","unstructured":"Uebersax J. User Guide for the MH Program (v. 1.2) Tests of marginal homogeneity for two-way tables.\u00a0http:\/\/www.john-uebersax.com\/stat\/mh.htm. Accessed 22 May 2021"},{"issue":"5","key":"6259_CR37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jbspin.2014.02.007","volume":"81","author":"I Hmamouchi","year":"2014","unstructured":"Hmamouchi I, Combe B, Fautrel B, Rincheval N, Lukas C (2014) Prevalence and concordance of early and sustained remission assessed by various validated indices in the early arthritis \u201cESPOIR\u201d cohort. Joint Bone Spine 81(5):409\u2013415. https:\/\/doi.org\/10.1016\/j.jbspin.2014.02.007","journal-title":"Joint Bone Spine"},{"key":"6259_CR38","unstructured":"Alma \u00d6G (2011) Comparison of robust regression methods in linear regression. Int J Comput Math Sci 6(9):409\u2013421"},{"issue":"6","key":"6259_CR39","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/annrheumdis-2013-204920","volume":"74","author":"R Fleischmann","year":"2015","unstructured":"Fleischmann R, van der Heijde D, Koenig AS, Pedersen R, Szumski A, Marshall L et al (2015) How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the simplified disease activity index? Ann Rheum Dis 74(6):1132\u20131137. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204920","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"6259_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10067-013-2468-z","volume":"33","author":"C Sheehy","year":"2014","unstructured":"Sheehy C, Evans V, Hasthorpe H, Mukhtyar C (2014) Revising DAS28 scores for remission in rheumatoid arthritis. Clin Rheumatol 33(2):269\u2013272. https:\/\/doi.org\/10.1007\/s10067-013-2468-z","journal-title":"Clin Rheumatol"},{"issue":"3","key":"6259_CR41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1046\/j.1365-2796.1996.30295851000.x","volume":"240","author":"P Wetteland","year":"1996","unstructured":"Wetteland P, R\u00f8ger M, Solberg HE, Iversen OH (1996) Population-based erythrocyte sedimentation rates in 3910 subjectively healthy Norwegian adults. A statistical study based on men and women from the Oslo area. J Int Med 240(3):125\u201331. https:\/\/doi.org\/10.1046\/j.1365-2796.1996.30295851000.x","journal-title":"J Int Med"},{"issue":"1","key":"6259_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s13075-017-1457-z","volume":"19","author":"S Jin","year":"2017","unstructured":"Jin S, Li M, Fang Y, Li Q, Liu J, Duan X et al (2017) Chinese Registry of rheumatoid arthritis (CREDIT): II. Prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis. Arthritis Res Ther 19(1):251. https:\/\/doi.org\/10.1186\/s13075-017-1457-z","journal-title":"Arthritis Res Ther"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06259-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06259-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06259-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T04:03:53Z","timestamp":1712376233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06259-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["6259"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06259-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"assertion":[{"value":"4 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}